Jefferies Raises Numbers On Impax Laboratories (IPXL) After Strong Q4; Maintains Hold Rating
Tweet Send to a FriendGet Alerts IPXL Hot Sheet
Price: $18.42 --0%
Rating Summary:
3 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 6
Rating Summary:
3 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 6
Trade IPXL Now!
Jefferies raised estimates and its price target on Impax Laboratories (NASDAQ: IPXL) from $17 to $21 after the company "crushed" Q4 views on higher generic Adderall XR revenue.
The firm comments, "The big question: what’s the AXR run-rate going forward? That’s uncertain w/ no guidance, even qualitative, but we already assume IPXL/Shire work it out and AXR is up 26% in ‘12. IPXL’s confident in Warning Letter resolution soon. That would be great, but likely already in the #’s. We raise target to $21, on increased ests. and higher multiple."
Q1 EPS was raised from $0.52 to $0.53, FY12 from $1.88 to $1.92 and FY13 from $1.35 to $1.42.
For an analyst ratings summary and ratings history on Impax Laboratories click here. For more ratings news on Impax Laboratories click here.
Shares of Impax Laboratories closed at $23.62 yesterday, with a 52 week range of $14.46-$28.75.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm comments, "The big question: what’s the AXR run-rate going forward? That’s uncertain w/ no guidance, even qualitative, but we already assume IPXL/Shire work it out and AXR is up 26% in ‘12. IPXL’s confident in Warning Letter resolution soon. That would be great, but likely already in the #’s. We raise target to $21, on increased ests. and higher multiple."
Q1 EPS was raised from $0.52 to $0.53, FY12 from $1.88 to $1.92 and FY13 from $1.35 to $1.42.
For an analyst ratings summary and ratings history on Impax Laboratories click here. For more ratings news on Impax Laboratories click here.
Shares of Impax Laboratories closed at $23.62 yesterday, with a 52 week range of $14.46-$28.75.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- In-Line Q4 Results Expected for NetApp (NTAP); Elliott Investment Will Take Time to Pan Out
- Wells Fargo Downgrades Brinker Int'l (EAT) to Market Perform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
